Autopsy report · NCT01875107

Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients

“Time constraints of primary investigator.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

University of Minnesota

Sponsor type

University, hospital or other

Conditions

Hyperglycemia in Pregnant Diabetic Patients

Interventions

insulin pre-treatment

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Autologous, Culture-Expanded Mesenchymal Stromal Cells for Degenerative Disc Disease
  “Principal Investigator transition” (69% match in meaning)
• Assessment of Emotional Memory During Transient Global Amnesia
  “Departure of the principal investigator” (67% match in meaning)
• Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection
  “Primary investigator left institution” (67% match in meaning)
• Acute Myocardial Necrosis and Depression: Antiplatelet Effect of Reuptake Inhibition of Serotonin
  “Investigator's decision” (65% match in meaning)
• Links Between Perception of Temporal Order Judgment and Causality in Schizophrenia
  “Investigator departure” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.